Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS033618-02
Application #
2272520
Study Section
Neurology A Study Section (NEUA)
Project Start
1995-08-15
Project End
1999-05-31
Budget Start
1996-08-10
Budget End
1997-05-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Oregon Health and Science University
Department
Neurology
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239

  Publications

Weinstein, Jason S; Varallyay, Csanad G; Dosa, Edit et al. (2010) Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 30:15-35
Li, Xin; Rooney, William D; Várallyay, Csanád G et al. (2010) Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination. J Magn Reson 206:190-9
Thompson, Eric M; Dosa, Edit; Kraemer, Dale F et al. (2010) Treatment with bevacizumab plus carboplatin for recurrent malignant glioma. Neurosurgery 67:87-93
Jahnke, Kristoph; Muldoon, Leslie L; Varallyay, Csanad G et al. (2009) Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma. Neuro Oncol 11:503-13
Varallyay, Csanad G; Muldoon, Leslie L; Gahramanov, Seymur et al. (2009) Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model. J Cereb Blood Flow Metab 29:853-60
Wu, Yingjen Jeffrey; Muldoon, Leslie L; Dickey, Dana Thomas et al. (2009) Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models. Neoplasia 11:187-95
Neuwelt, Edward A; Hamilton, Bronwyn E; Varallyay, Csanad G et al. (2009) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int 75:465-74
Jahnke, Kristoph; Muldoon, Leslie L; Varallyay, Csanad G et al. (2009) Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model. Neuro Oncol 11:142-50
Jahnke, Kristoph; Kraemer, Dale F; Knight, Kristin R et al. (2008) Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer 112:581-8
Stenstrom, David A; Muldoon, Leslie L; Armijo-Medina, Hector et al. (2008) N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials. J Vasc Interv Radiol 19:309-18

Showing the most recent 10 out of 58 publications